In this relatively limited material, there were no significant differences when comparing the infiltration into the actual tumor mass of all CD3+ T cells, CD8+ cytotoxic T cells, Treg, or γδ T cells between relapsing and relapse-free patients (Figure 7B–E). The gene discussed is CD8A; the disease is neoplasm.